This message was sent to ##Email##
|
|
|
|
|
UCLA
A new research paper examining the 2014-15 Ebola outbreak in Africa could hold crucial insights for policymakers grappling with the novel coronavirus pandemic — namely, the importance of public engagement and trust during health crises.
The study, co-authored by Darin Christensen, assistant professor of public policy in the UCLA Luskin School of Public Affairs, shows that where people lack confidence in their health providers, they are less likely to seek testing and treatment when they feel sick.
READ MORE
Stanford Medicine via ScienceDaily
Old human cells return to a more youthful and vigorous state after being induced to briefly express a panel of proteins involved in embryonic development, according to a new study by researchers at the Stanford University School of Medicine.
The researchers also found that elderly mice regained youthful strength after their existing muscle stem cells were subjected to the rejuvenating protein treatment and transplanted back into their bodies.
READ MORE
University of Cambridge via Phys.org
A new multinational study has shown how the process of distinguishing viruses and bacteria could be accelerated through the use of computational methods.
The researchers, led by the University of Edinburgh, with colleagues from Cambridge, London, Slovenia and China, used a combination of theoretical and experimental methods to develop a strategy to detect the DNA of infectious diseases.
READ MORE
Lab Manager
Lately, it’s been hard to miss all the news articles about rising ocean temperatures and plastics in the environment and our food chain. Fortunately, there seems to be many things we, as individuals, can do about it — from using reusable bags to riding a bike to work to changing our diets.
READ MORE
 |
|
Promoted by
Sol-Millennium
SOL-MILLENNIUM is a global medical company. We serve healthcare professionals and patients across the world.
At SOL-MILLENNIUM we know what we do best – we make high quality, affordable medical devices that are familiar, safe and easy to use.
We specialize in medication delivery, blood collection, diabetes care and animal health.
Meet us at AACC, Chicago 28-30 July, booth 5357
|
|
CNN
There's a lot about Iceland that other countries could envy: Its spectacular natural surroundings, its place among the world's happiest countries and, now, its large-scale testing for the novel coronavirus, which could influence how the world understands the outbreak.
Experts have said comprehensive testing is key to controlling coronavirus, and creating a more accurate picture of the spread of COVID-19.
READ MORE
 |
|
The miniiSED® is the newest addition to the iSED® family of ESR analyzers from ALCOR Scientific. The miniiSED®is a single position, fully automated ESR analyzer that works directly from the primary EDTA tube and produces an ESR result in just 15 seconds. The miniiSED® is the ideal ESR analyzer for small laboratories, POL’s and emergency clinics.
|
|
Infection Control Today
Ultraviolet light can destroy pathogenic bacteria, including Clostridioides difficile spores, but measuring the effectiveness of UV can be tricky, as investigators with Penn State Health, Milton S. Hershey Medical Center, found out. Their recent study in the American Journal of Infection Control describes the impact of portable pulsed-xenon UV disinfecting devices in six units of their hospital that had registered high C. diff infection rates.
READ MORE
|
|
Healio
In a small study conducted in China, many patients with mild cases of COVID-19 infection continued to test positive for the virus up to eight day after their symptoms had resolved, according to a research letter published in the American Journal of Respiratory and Critical Care Medicine.
“The most significant finding from our study is that half of the patients kept shedding the virus even after resolution of their symptoms,” Lokesh Sharma, Ph.D., instructor of medicine in the section of pulmonary, critical care and sleep medicine at Yale School of Medicine, said in a press release.
READ MORE
The New York Times
An experimental stem cell therapy derived from human placentas will begin early testing in patients with the coronavirus, a New Jersey biotech company said.
The treatment, being developed by the company Celularity, has not yet been used on any patients with symptoms of COVID-19, but it has caught the attention of Rudy Giuliani, Trump’s personal lawyer.
READ MORE
Advertisement
American Medical Technologists
 Enhance your credentials to work in the rapidly expanding field of molecular diagnostics
|
Medical News Today
Prostate tumors that contain more of a specific type of cell are more likely to be life-threatening, a new study has found. The research could lead to a test to differentiate between aggressive and harmless forms of the disease.
READ MORE
|
Promoted by
|
|
|
|
 |
Infection Control Today
Think of it, says Dr. Vineet Chopra, MSc, as being a sort of Good Housekeeping Seal of Approval for infection prevention products. Chopra is chief of the division of hospital medicine at VA Ann Arbor Health System.
READ MORE
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests.
Learn more
|
|
|
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, contact Andy Keith at 972-402-7707.
MORE
|
|
|
|
ContagionLive
Investigators from the University of California San Diego School of Medicine want to examine the effect of breast milk in transmitting or offering a protective effect in two new studies, according to a press release.
The first study will be conducted in collaboration between the school and the Family Larsson-Rosenquist Foundation, which is donating $100,000 in order to streamline the process of assisting investigators at the Mother-Milk Infant Center of Research Excellence, the statement added.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
